MicroTransponder Secures $3,895,682 Series C Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2802 Flintrock Trace Austin, TX 78738 USA
  • Company Description
    MicroTransponder Inc. is a medical device development company with a strong neuroscience research focus. Our core technology is based on a previous technology developed in the DARPA Revolutionizing Prosthetics program by Dr. Larry Cauller at the University of Texas at Dallas.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
  • M&A Terms
  • Venture Investor

Trending on Xconomy